Cannara Biotech Inc (LOVE : TSX-V)
Common Stock
Follow LOVE
LOVE
Cannara Biotech Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
+2.81%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$181.03M
52W High
$2.07
52W Low
$1.06
P/E Ratio
15.75
50 Day MA
$1.81
200 Day MA
$1.69
Beta
0.34
Dividend Yield
-
Performance history
LOVE returns since 2023
Cannara Biotech Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −45.1% (Mar 2024 to Jul 2024).
1 year / yr
+30.7%
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−12.6%
- 2024−10.8%
- 2025+135.1%
- 2026*+5.2%
* Partial year (first year of data, or year to date).
$10,000 invested in LOVE
- 1 year ago$13,071
- 2023 (start of our data)$19,263
- Best year
- 2025: +135.1%
- Worst year
- 2024: −10.8%
- All-time high in our data
- $2 on Jan 22, 2026 · now −7.6%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Mar 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past LOVE? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Cannara Biotech Inc insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Jul 29, 26 | Buy | Olymbec Investments Inc. Company · CA$96,500 | 50,000 | CA$1.93 |
| Jun 02, 26 | Buy | Sosiak, Nicholas Individual · CA$28,560 | 16,800 | CA$1.70 |
| Feb 11, 26 | Sell | Krivorot, Zohar Individual · CA$699,999 | 333,333 | CA$2.10 |
| Oct 07, 25 | Buy | Stern, Derek Elan Individual · CA$6.2m | 3,462,763 | CA$1.80 |
| Oct 01, 25 | Buy | Olymbec Investments Inc. Company · CA$6.2m | 3,462,763 | CA$1.80 |
| May 06, 25 | Buy | Olymbec Investments Inc. Company · CA$349,950 | 250,000 | CA$1.40 |
| May 01, 25 | Buy | Olymbec Investments Inc. Company · CA$138,274 | 97,900 | CA$1.41 |
| Feb 28, 25 | Buy | Sherman, Brian Individual · CA$973 | 700 | CA$1.39 |
| Jan 31, 25 | Buy | Olymbec Investments Inc. Company · CA$13,500 | 12,500 | CA$1.08 |
| Dec 12, 24 | Buy | Sosiak, Nicholas Individual · CA$7,600 | 10,704 | CA$0.71 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 3/24/2026 | $1.87 | $1.87 | $1.80 | $1.83 | $1.83 | 19,054 |
| 3/2/2026 | $1.90 | $1.90 | $1.84 | $1.87 | $1.87 | 23,891 |
| 2/27/2026 | $1.84 | $1.89 | $1.78 | $1.89 | $1.89 | 63,183 |
| 2/26/2026 | $1.85 | $1.85 | $1.75 | $1.78 | $1.78 | 111,596 |
| 2/25/2026 | $1.79 | $1.80 | $1.78 | $1.78 | $1.78 | 37,827 |
| 2/24/2026 | $1.83 | $1.86 | $1.78 | $1.80 | $1.80 | 50,841 |
| 2/23/2026 | $1.83 | $1.90 | $1.74 | $1.76 | $1.76 | 151,715 |
| 2/20/2026 | $1.88 | $1.88 | $1.82 | $1.83 | $1.83 | 8,714 |
| 2/19/2026 | $1.85 | $1.91 | $1.84 | $1.89 | $1.89 | 62,587 |
| 2/18/2026 | $1.83 | $1.86 | $1.82 | $1.84 | $1.84 | 18,910 |
Analyst Price Targets
Based on analyst covering LOVE · as of Sep 17, 2026
Wall Street analysts forecast LOVE stock price to rise 65.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+65.4% Upside
Current Price
C$2.04
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
47.9%
Annualized
90-Day Vol
42.2%
Annualized
Trend (90d)
+30.9%
Annualized drift
90d Mean
C$2.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.90 | C$1.61 – C$2.24 |
| 60 trading days | C$1.97 | C$1.56 – C$2.49 |
| 90 trading days | C$2.04 | C$1.54 – C$2.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cannara Biotech Inc
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Financials
- Revenue (TTM)
- $112.25M
- EBITDA
- $26.56M
- Profit Margin
- 10.52%
- ROE (TTM)
- 11.71%
- EPS (Diluted)
- 0.12
- Book Value
- 1.17
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About LOVE
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.